Low expression of PRMT5 in peripheral blood may serve as a potential independent risk factor in assessments of the risk of stable CAD and AMI

Peer Review reports

Original Submission
16 Sep 2018	Submitted	Original manuscript
6 Oct 2018	Reviewed	Reviewer Report - Jacek Bil
18 Dec 2018	Reviewed	Reviewer Report - Alexandre Stewart
1 Jan 2019	Author responded	Author comments - Buchuan Tan
Resubmission - Version 2
1 Jan 2019	Submitted	Manuscript version 2
15 Jan 2019	Reviewed	Reviewer Report - Jacek Bil
21 Jan 2019	Reviewed	Reviewer Report - Alexandre Stewart
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
23 Jan 2019	Editorially accepted
31 Jan 2019	Article published	10.1186/s12872-019-1008-4

Back to article page